Modeling and meta-analysis are powerful tools for providing payers with vital information on which to base their decisions when assessing the costs and/or benefits of healthcare interventions.
When payers make decisions about which technologies and/or services to fund, they must assess the clinical and economic value of feasible alternatives through a consideration of costs and appropriate outcomes over an appropriate time horizon for a range of patient subgroups.
Clinical trials are designed for measurement and hypothesis testing, so they often fail to meet the requirements for decision-making.
Our team of experts joined OPEN Health through the merger with Pharmerit and have pioneered innovative methodologies in a range of therapy areas.
Methods to account for treatment sequencing
Applications of Q-TWiST in immuno-oncology
Development of two-eyes ophthalmology models
Use of Bayesian statistics in comparative effectiveness
Use and expansion of mixed modeling methods in survival analysis
We are committed to providing an unrivaled mix of technical expertise and strategic insights in the field of health-economic modeling and evidence synthesis. With our bespoke approach, we work with you to assess your needs and develop a solution that is right fitted to you.
Our modeling experts will guide you to apply communication and analysis tools to meet many research challenges.
Engaging presentation of simple or complex analysis for Excel or mobile devices
Communication and analysis tools to meet many research challenges
Simple digital platforms for data collection and immediate analysis
Our modeling experts are actively involved in the field. We have the experience needed to partner with you in research and guide you to the right solutions.
HTA submissions supported worldwide
Cost-effectiveness models delivered
To learn more about our modeling and meta-analysis research and discuss what we could do for you, please get in touch.
Modeling & Meta-Analysis Lead